Modulation of phosphatidylethanolamine biosynthesis by exogenous ethanolamine and analogues in the hamster heart.
In the hamster heart, exogenous ethanolamine is taken up by the heart and utilized for the biosynthesis of phosphatidylethanolamine. The role of the exogenous supply of ethanolamine on phosphatidylethanolamine biosynthesis was examined by perfusing hamster heart with various concentrations of labelled ethanolamine. Analysis of the radioactivity distributed in the ethanolamine-containing metabolites indicated that at low exogenous ethanolamine concentrations (< or = 0.1 microM), the conversion of phosphoethanolamine to CDP-ethanolamine was rate-limiting for phosphatidylethanolamine biosynthesis. However, perfusion with higher concentrations of ethanolamine (> or = 0.4 microM) resulted in the phosphorylation of ethanolamine becoming rate-limiting. Since the intracellular ethanolamine levels remained unchanged, the alterations in radioactivity distribution suggested that the newly imported ethanolamine was preferentially utilized for phosphatidylethanolamine biosynthesis. The effects of ethanolamine analogues on ethanolamine uptake and subsequent conversion to phosphatidylethanolamine at physiological concentrations of exogenous ethanolamine were examined. Monomethylethanolamine was found to inhibit ethanolamine uptake, the conversion of ethanolamine to phosphoethanolamine and incorporation of radioactivity into phosphatidylethanolamine. The accumulation of radioactivity in the ethanolamine fraction by monomethylethanolamine, despite of the inhibition of ethanolamine uptake, further confirms the rate-limiting role of ethanolamine kinase in the biosynthesis of phosphatidylethanolamine.
McMaster
C R
CR
Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
Tardi
P G
PG
Choy
P C
PC
D000409:Alanine / Q000494:pharmacology; D000818:Animals; D006224:Cricetinae; D003565:Cytidine Diphosphate / Q000031:analogs & derivatives / Q000378:metabolism; D003642:Deanol / Q000494:pharmacology; D019856:Ethanolamine; D004983:Ethanolamines / Q000378:metabolism* / Q000494:pharmacology; D005998:Glycine / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D007700:Kinetics; D008647:Mesocricetus; D009206:Myocardium / Q000378:metabolism*; D010714:Phosphatidylethanolamines / Q000096:biosynthesis*
D004983:Ethanolamines; D010714:Phosphatidylethanolamines; D003642:Deanol; C006933:CDP ethanolamine; D019856:Ethanolamine; D003565:Cytidine Diphosphate; D000409:Alanine; D005998:Glycine; C017500:N-methylaminoethanol